January 2024

Board Moves.

Below is a list of all corporate board appointments and resignations in this sector from last month.

Appointments & Departures.

2Seventy Bio (NASDAQ: TSVT)

Promotes William Baird to CEO and he is appointed to the Board of Directors.

Arcus Biosciences (NYSE: RCUS)

Appoints Johanna Mercier to the Board of Directors. Ms. Mercier is the Chief Commercial Officer at Gilead Sciences.

AtriCure (NASDAQ: ATRC)

Appoints Shlomi Nachman to the Board of Directors. Mr. Nachman is the former Company Group Chair at Johnson & Johnson.

Autolus Therapeutics (NASDAQ: AUTL)

Appoints Robert Azelby to the Board of Directors. Mr. Azelby is the former CEO at Eliem Therapeutics.

BeiGene (NASDAQ: BGNE)

Appoints Olivier Brandicourt to the Board of Directors. Mr. Brandicourt is the former CEO at Sanofi SA.

Charles River Laboratories Int’l (NYSE: CRL)

Appoints Reshema Kemps-Polanco to the Board of Directors. Ms. Kemps-Polanco is the Chief Commercial Officer at Novartis US.

Day One Biopharmaceuticals (NASDAQ: DAWN)

Appoints Habib Dable and William Grossman to the Board of Directors. Mr. Dable is the former CEO at Acceleron Pharma and Mr. Grossman is a SVP at Gilead Sciences.

Exelixis (NASDAQ: EXEL)

Appoints Mary Beckerle and Gail Eckhardt to the Board of Directors. Ms. Beckerle is the CEO at Huntsman Cancer Institute and Ms. Eckardt is the Associate Dean at Baylor College of Medicine.

Immunome (NASDAQ: IMNM)

Appoints Carol Schafer to the Board of Directors. Ms. Schafer is a Managing Partner at Hyphen Advisors.

Insulet (NASDAQ: PODD)

Appoints Flavia Pease and Tim Stonesifer to the Board of Directors. Ms. Pease is the CFO at Charles River Lab and Mr. Stonesifer is the CFO at Alcon.

Masimo (NASDAQ: MASI)

Appoints Robert Chapek to the Board of Directors. Mr. Chapek is the former CEO at Walt Disney Company.

McKesson (NYSE: MCK)

Appoints Kevin Ozan to the Board of Directors. Mr. Ozan is the former CFO at McDonald’s.

NewAmsterdam Pharma Company NV (NASDAQ: NAMS)

Appoints Willian Lewis to the Board of Directors. Mr. Lewis is the CEO at Insmed.

Nuvation Bio (NYSE: NUVB)

Appoints Robert Mashal to the Board or Directors. Mr. Mashal is the former Global Head of Strategy at Sanofi.

Orthofix Medical (NASDAQ: OFIX)

Names Massimo Calafiore CEO and he is appointed to the Board of Directors.

SIGA Technologies (NASDAQ: SIGA)

Names Diem Nguyen CEO and he is appointed to the Board of Directors. Mr. Nguyen is the former CEO at Xalud Therapeutics.

Zevra Therapeutics (NASDAQ: ZVRA)

Appoints Alvin Shih to the Board of Directors. Mr. Shih is the former CEO at Catamaran Bio.

Zimmer Biomet (NYSE: ZBH)

Appoints Louis Shapiro to the Board of Directors. Mr. Shapiro is the former CEO at Hospital for Special Surgery.

4D Molecular Therapeutics (NASDAQ: FDMT)

Noriyuki Kasahara resigns from the Board of Directors. Mr. Kasahara is the Chief Scientific Officer at 4D Molecular Therapeutics.

AngioDynamics (NASDAQ: ANGO)

Dennis Meteny resigns from the Board of Directors. Mr. Meteny is the CEO at Cygnus Manufacturing Company.

Avidity Biosciences (NASDAQ: RNA)

Eric Mosbrooker resigns from the Board of Directors and is named Chief Strategy Officer.

AxoGen (NASDAQ: AXGN)

Karen Zaderej to retire as CEO and from the Board of Directors.

Cencora (NYSE: COR)

Henry McGee retires from the Board of Directors. Mr. Mcgee is the former President at HBO Home Entertainment.

Hologic (NASDAQ: HOLX)

Namal Nawana departs from the Board of Directors. Mr. Nawana is the former CEO at Smith & Nephew.

Inspire Medical Systems (NYSE: INSP)

Jerry Griffin retires from the Board of Directors. Mr. Griffin is the President at Griffin & Schwartz Scientific Services.

Onconetix (NASDAQ: ONCO)

Neil Campbell resigns as CEO and from the Board of Directors.

SAGE Therapeutics (NASDAQ: SAGE)

Kevin Starr resigns from the Board of Directors. Mr. Starr is the Co-Founder at Third Rock Ventures.

Zentalis Pharmaceuticals (NASDAQ: ZNTL)

Diana Hausman resigns from the Board of Directors. Ms. Hausman is the Chief Medical Officer at Zentalis Pharmaceuticals.

Read the Full Issue
READ NOW